Literature DB >> 17660025

Relationship of uric acid with progression of kidney disease.

Michel Chonchol1, Michael G Shlipak, Ronit Katz, Mark J Sarnak, Anne B Newman, David S Siscovick, Bryan Kestenbaum, Jan Kirk Carney, Linda F Fried.   

Abstract

BACKGROUND: Uric acid levels are increased in patients with kidney dysfunction. We tested the hypothesis that uric acid may be associated with kidney disease progression. STUDY
DESIGN: Cohort study. SETTING & PARTICIPANTS: 5,808 participants of the Cardiovascular Health Study. PREDICTOR: Uric acid levels. OUTCOMES & MEASUREMENTS: Kidney disease progression was defined as a decrease in estimated glomerular filtration rate (GFR) of 3 mL/min/1.73 m(2) per year or greater (>or=0.05 mL/s) and as incident chronic kidney disease (CKD). Measures of kidney function were estimated GFR using the Modification of Diet in Renal Disease Study equation.
RESULTS: Higher quintiles of uric acid levels were associated with greater prevalences of estimated GFR less than 60 mL/min/1.73 m(2) (<1.00 mL/s) of 7%, 14%, 12%, 25%, and 42% for quintiles 1 (<or=4.41 mg/dL [<or=262 micromol/L]), 2 (4.41 to 5.20 mg/dL [262 to 309 micromol/L]), 3 (5.21 to 5.90 mg/dL [310 to 351 micromol/L]), 4 (5.91 to 6.90 mg/dL [352 to 410 micromol/L]), and 5 (>6.90 mg/dL [>410 micromol/L]), respectively. In comparison, there was only a modest, but significant, association between quintiles of uric acid levels and progression of kidney function decrease, with adjusted odds ratios of 1.0, 0.88 (95% confidence interval [CI], 0.64 to 1.21), 1.23 (95% CI, 0.87 to 1.75), 1.47 (95% CI, 1.04 to 2.07), and 1.49 (95% CI, 1.00 to 2.22) for quintiles 1 through 5, respectively. No significant association was found between uric acid level and incident CKD (adjusted odds ratio, 1.00; 95% CI, 0.89 to 1.14). LIMITATIONS: Measurements of albuminuria were not available.
CONCLUSIONS: Uric acid levels are associated strongly with prevalent CKD. In comparison, greater uric acid levels had a significant, but much weaker, association with progression of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660025     DOI: 10.1053/j.ajkd.2007.05.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  148 in total

1.  The relationship between serum uric acid and chronic kidney disease among Appalachian adults.

Authors:  Loretta Cain; Anoop Shankar; Alan M Ducatman; Kyle Steenland
Journal:  Nephrol Dial Transplant       Date:  2010-05-25       Impact factor: 5.992

2.  Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.

Authors:  Mayuree Tangkiatkumjai; Dawn-Marie Walker; Kearkiat Praditpornsilpa; Helen Boardman
Journal:  Clin Exp Nephrol       Date:  2016-07-20       Impact factor: 2.801

3.  Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Authors:  Stacey E Jolly; Mihriye Mete; Hong Wang; Jianhui Zhu; Sven O E Ebbesson; V Saroja Voruganti; Anthony G Comuzzie; Barbara V Howard; Jason G Umans
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-04       Impact factor: 3.738

Review 4.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 5.  SLC2A9--a fructose transporter identified as a novel uric acid transporter.

Authors:  Myphuong T Le; Mohamed Shafiu; Wei Mu; Richard J Johnson
Journal:  Nephrol Dial Transplant       Date:  2008-07-07       Impact factor: 5.992

Review 6.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

7.  Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Andrew S Bomback; Ronit Katz; Ka He; David A Shoham; Gregory L Burke; Philip J Klemmer
Journal:  Am J Clin Nutr       Date:  2009-09-09       Impact factor: 7.045

8.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

9.  Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study.

Authors:  Tapan Mehta; Petra Bůžková; Mark J Sarnak; Michel Chonchol; Jane A Cauley; Erin Wallace; Howard A Fink; John Robbins; Diana Jalal
Journal:  Metabolism       Date:  2014-11-21       Impact factor: 8.694

10.  Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

Authors:  Imed Helal; Kim McFann; Berenice Reed; Xiang-Dong Yan; Robert W Schrier; Godela M Fick-Brosnahan
Journal:  Nephrol Dial Transplant       Date:  2012-12-04       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.